Data released at the European Society of Medical Oncology meeting over the weekend showed much progress in fighting a number of cancers. Here's what investors need to know.» Read More
The potential for Pfizer to take over AstraZeneca has sent its prey’s share price soaring and caused political ructions on both sides of the Atlantic.
Roche's deal for InterMune is one of the few this year that returns to the traditional model of big pharma buying smaller biotech.
Walgreen pharmacies are back online after earlier reporting that many stores couldn't fill prescriptions due to a database failure, Dow Jones said.
50 Cent nominated rival Floyd Mayweather to an Ice Bucket Challenge that didn't involve a bucket of ice water or the ALS Foundation.
Dr. Kent Brantly's release came two days after a second U.S. missionary, Nancy Writebol, was quietly allowed to leave Emory University Hospital.
The FBI has warned that health care industry companies are being targeted by hackers.
Despite the fact that more than a third of U.S. adults are obese, it's been an uphill battle for developers of obesity treatments.
GameStop said Chief Executive Paul Raines underwent an unexpected surgery last week for a small cancerous brain tumor.
Chugai shares rose 21 percent following a media report that Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese firm.
FedEx was indicted in a U.S. criminal case for conspiracy to launder money over deliveries for illegal online pharmacies.
"Three weeks ago, half the population didn't know what ALS is," ALS Association Development Officer Lance Slaughter tells CNBC. "Now millions of people do."
Barbara Ryan, FTI Consulting, discusses the tremendous amount of innovation within in the biotech sector and why the segment is attractive.
The bets against smaller biotech firms are usually stock specific, but the industry as a whole offers unique opportunities for short sellers.
Blackstone Advisory's Byron Wien still sees a 20 percent return for the S&P 500 for 2014, but he admits there are things that keep him up at night.
Propelled by Facebook and Twitter, the ice bucket challenge has become a viral sensation. Now Biogen executives and CNBC are rising to the challenge.
The FDA approved the first screening test for colon cancer that uses patients' DNA to help spot potentially deadly tumors and growths.
Is the world ready for genetically modified babies? Here's how close we really are, explains Jessica Cussins of the Center for Genetics and Society.
Tekmira Pharmaceutical's stocks have soared since the U.S. Food and Drug Administration cleared its experimental Ebola drug for human use.
Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its drug Lipitor.
Looking to trade on the Ebola scare? Ex-trader Turney Duff offers up what he'd do—and a word of caution.
Get the best of CNBC in your inbox